Skip to main content
logo
The Cooper Companies, Inc. (BVMF:C1OO34)
Brazil flag Brazil · Delayed Price · Currency is BRL
44.08
+0.12 (0.27%)
At close: Dec 15, 2025

Revenue

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 2012 - 2021
Toric Lens Revenue
-
Log In
Log In
Log In
Upgrade
Multifocal Lens Revenue
-
Log In
Log In
Log In
Upgrade
Toric and Multifocal Revenue
1.35B
Log In
Log In
Log In
Upgrade
Single-Use Sphere Lens Revenue
-
Log In
Log In
Log In
Upgrade
Non Single-Use Sphere Lens and Other Revenue
-
Log In
Log In
Log In
Upgrade
Sphere, Other Revenue
1.39B
Log In
Log In
Log In
Upgrade
Total CooperVision Revenue
2.74B
Log In
Log In
Log In
Upgrade
Office and Surgical Products Revenue
824.00M
Log In
Log In
Log In
Upgrade
Fertility Revenue
524.60M
Log In
Log In
Log In
Upgrade
Total CooperSurgical Revenue
1.35B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-2.74B
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.09B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 2012 - 2021
United States Revenue
2.05B
Log In
Log In
Log In
Upgrade
Europe Revenue
1.25B
Log In
Log In
Log In
Upgrade
Rest Of The World Revenue
785.20M
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.09B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 2012 - 2021
CooperVision Operating Income
729.60M
Log In
Log In
Log In
Upgrade
CooperSurgical Operating Income
43.40M
Log In
Log In
Log In
Upgrade
Corporate Operating Income
-90.10M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
682.90M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
FY 2025FY 2024FY 2023FY 20222012 - 2021
Period Ending
Oct '25 Oct '24 Oct '23 Oct '22 2012 - 2021
CooperVision - Constant Currency Revenue Growth
5.00%
Log In
Log In
Log In
Upgrade
CooperSurgical - Constant Currency Revenue Growth
5.00%
Log In
Log In
Log In
Upgrade
Total Company - Constant Currency Revenue Growth
5.00%
Log In
Log In
Log In
Upgrade
CooperVision - Organic Revenue Growth
5.00%
Log In
Log In
Log In
Upgrade
CooperSurgical - Organic Revenue Growth
3.00%
Log In
Log In
Log In
Upgrade
Total Company - Organic Revenue Growth
4.00%
Log In
Log In
Log In
Upgrade
Updated Oct 31, 2025. Data Source: Fiscal.ai.